2019
DOI: 10.1016/j.bbapap.2019.01.013
|View full text |Cite
|
Sign up to set email alerts
|

Secretome analysis of human bone marrow derived mesenchymal stromal cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
28
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6
3

Relationship

3
6

Authors

Journals

citations
Cited by 43 publications
(28 citation statements)
references
References 50 publications
0
28
0
Order By: Relevance
“…In a recent approach, we described the comparison of abundances of secreted and cellular proteins as a valuable tool to select proteins that are enriched in the secretome and therefore probably secreted 15 . Using this approach in ten different experimental settings, including mouse, rat, and human cell types 16,17 , we developed a database containing proteins showing a high likelihood to be secreted in the respective systems (called secreted proteins in this chapter) as well as those showing very high likelihood to not be secreted (called cellular proteins in this chapter). The proteins that were secreted in at least three different experiments and did not contain a signal peptide and/or transmembrane domain (UniProt Annotation release May 2018) were selected as the training set for OutCyte-UPS.…”
Section: Methodsmentioning
confidence: 99%
“…In a recent approach, we described the comparison of abundances of secreted and cellular proteins as a valuable tool to select proteins that are enriched in the secretome and therefore probably secreted 15 . Using this approach in ten different experimental settings, including mouse, rat, and human cell types 16,17 , we developed a database containing proteins showing a high likelihood to be secreted in the respective systems (called secreted proteins in this chapter) as well as those showing very high likelihood to not be secreted (called cellular proteins in this chapter). The proteins that were secreted in at least three different experiments and did not contain a signal peptide and/or transmembrane domain (UniProt Annotation release May 2018) were selected as the training set for OutCyte-UPS.…”
Section: Methodsmentioning
confidence: 99%
“…Several mechanisms may contribute to tendon repair with exogenic BMSCs. First, BMSCs can differentiate into certain new cells (tenocytes) to replace lost normal cells[ 19 , 39 ]; second, BMSCs can secrete various cytokines and growth factors to promote the proliferation of cells in injured tissue[ 40 ]; and third, BMSCs can increase the deposition of collagenous proteins[ 41 ]. BMSC-based therapy has been found to improve histological and biomechanical properties and to increase the expression of collagen in animal injury[ 42 , 43 ].…”
Section: Endogenous and Exogenous Stem Cells/progenitors For Tendon Rmentioning
confidence: 99%
“…Pre-conditioning tendon cells by in-vitro culture with BM-MSCs secretome and further combining those cells with an electrospun keratin-based scaffold resulted in improved biomechanical performance in an in-vivo rat model of chronic massive rotator cuff tear [82]. These outcomes suggest a beneficial effect of BM-MSCs secretome, which has been demonstrated to include several growth factors, cytokines and other soluble molecules intervening in cellular growth and/or maintenance and signal transduction processes [83].…”
Section: Cell-based Therapies For Tendon Applicationsmentioning
confidence: 99%